Efficacy and Safety of Combination Comprising Tamsulosin and PDE5-Is, Relative to Monotherapies, in Treating Lower Urinary Tract Symptoms and Erectile Dysfunction Associated With Benign Prostatic Hyperplasia: A Meta-Analysis.
作者信息
Chai Yumeng, Zhang Yong
机构信息
Department of Urology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
出版信息
Am J Mens Health. 2021 Jan-Feb;15(1):1557988321997725. doi: 10.1177/1557988321997725.
Abstract
摘要
相似文献
1
Efficacy and Safety of Combination Comprising Tamsulosin and PDE5-Is, Relative to Monotherapies, in Treating Lower Urinary Tract Symptoms and Erectile Dysfunction Associated With Benign Prostatic Hyperplasia: A Meta-Analysis.坦索罗辛与5型磷酸二酯酶抑制剂联合用药相对于单药治疗良性前列腺增生相关下尿路症状和勃起功能障碍的疗效及安全性：一项荟萃分析
Am J Mens Health. 2021 Jan-Feb;15(1):1557988321997725. doi: 10.1177/1557988321997725.
2
Efficacy and Safety of Combination Comprising Tamsulosin and PDE5-Is, Relative to Monotherapies, in Treating Lower Urinary Tract Symptoms and Erectile Dysfunction Associated With Benign Prostatic Hyperplasia: A Meta-Analysis.坦索罗辛和 PDE5-I 联合治疗与单药治疗良性前列腺增生相关下尿路症状和勃起功能障碍的疗效和安全性：一项荟萃分析。
Am J Mens Health. 2020 Nov-Dec;14(6):1557988320980180. doi: 10.1177/1557988320980180.
3
Tadalafil Alone or in Combination with Tamsulosin for the Management for LUTS/BPH and ED.他达拉非单药治疗或联合坦索罗辛治疗下尿路症状/良性前列腺增生伴勃起功能障碍
Curr Urol Rep. 2020 Oct 27;21(12):56. doi: 10.1007/s11934-020-01009-7.
4
Comparison of Monotherapies and Combination Therapy of Tamsulosin and Tadalafil for Treating Lower Urinary Tract Symptoms Caused by Benign Prostatic Hyperplasia with or without Erectile Dysfunction: A Meta-Analysis.坦索罗辛与他达拉非单药治疗及联合治疗良性前列腺增生伴或不伴勃起功能障碍所致下尿路症状的比较：一项荟萃分析。
Urol Int. 2024;108(2):89-99. doi: 10.1159/000535606. Epub 2023 Dec 11.
5
Efficacy and safety of tadalafil 5 mg once-daily in Asian men with both lower urinary tract symptoms associated with benign prostatic hyperplasia and erectile dysfunction: A phase 3, randomized, double-blind, parallel, placebo- and tamsulosin-controlled study.他达拉非5毫克每日一次治疗伴有良性前列腺增生相关下尿路症状和勃起功能障碍的亚洲男性的疗效和安全性：一项3期、随机、双盲、平行、安慰剂和坦索罗辛对照研究。
Int J Urol. 2019 Feb;26(2):192-200. doi: 10.1111/iju.13828. Epub 2018 Oct 25.
6
A comparative randomized prospective study to evaluate efficacy and safety of combination of tamsulosin and tadalafil vs. tamsulosin or tadalafil alone in patients with lower urinary tract symptoms due to benign prostatic hyperplasia.一项比较随机前瞻性研究，旨在评估坦索罗辛和他达拉非联合与坦索罗辛或他达拉非单药治疗良性前列腺增生所致下尿路症状的疗效和安全性。
J Sex Med. 2014 Jan;11(1):187-96. doi: 10.1111/jsm.12357. Epub 2013 Oct 25.
7
Efficacy and Safety of a Fixed-Dose Combination Therapy of Tamsulosin and Tadalafil for Patients With Lower Urinary Tract Symptoms and Erectile Dysfunction: Results of a Randomized, Double-Blinded, Active-Controlled Trial.坦索罗辛与他达拉非固定剂量联合治疗下尿路症状和勃起功能障碍患者的疗效与安全性：一项随机、双盲、活性对照试验的结果
J Sex Med. 2017 Aug;14(8):1018-1027. doi: 10.1016/j.jsxm.2017.06.006.
8
A Systematic Review and Meta-Analysis of the Efficacy and Safety of Tamsulosin Plus Tadalafil Compared With Tamsulosin Alone in Treating Males With Lower Urinary Tract Symptoms Secondary to Benign Prostrate Hyperplasia.坦索罗辛联合他达拉非与坦索罗辛单药治疗良性前列腺增生症下尿路症状男性患者的疗效和安全性的系统评价和荟萃分析。
Am J Mens Health. 2023 Jan-Feb;17(1):15579883231155096. doi: 10.1177/15579883231155096.
9
Which Drug to Discontinue 3 Months After Combination Therapy of Tadalafil plus Tamsulosin for Men with Lower Urinary Tract Symptom and Erectile Dysfunction? Results of a Prospective Observational Trial.联合他达拉非和坦索罗辛治疗下尿路症状和勃起功能障碍 3 个月后应停用哪种药物？一项前瞻性观察性试验的结果。
Eur Urol Focus. 2021 Mar;7(2):432-439. doi: 10.1016/j.euf.2019.09.015. Epub 2019 Oct 10.
10
Defining the Efficacy and Safety of Phosphodiesterase Type 5 Inhibitors with Tamsulosin for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia with or without Erectile Dysfunction: A Network Meta-Analysis.定义磷酸二酯酶 5 抑制剂联合坦索罗辛治疗良性前列腺增生伴或不伴勃起功能障碍下尿路症状的疗效和安全性：网络荟萃分析。
Biomed Res Int. 2020 Mar 26;2020:1419520. doi: 10.1155/2020/1419520. eCollection 2020.
本文引用的文献
1
Efficacy and Safety of Combination Comprising Tamsulosin and PDE5-Is, Relative to Monotherapies, in Treating Lower Urinary Tract Symptoms and Erectile Dysfunction Associated With Benign Prostatic Hyperplasia: A Meta-Analysis.坦索罗辛和 PDE5-I 联合治疗与单药治疗良性前列腺增生相关下尿路症状和勃起功能障碍的疗效和安全性：一项荟萃分析。
Am J Mens Health. 2020 Nov-Dec;14(6):1557988320980180. doi: 10.1177/1557988320980180.
2
Tamsulosin and placebo vs tamsulosin and tadalafil in male lower urinary tract symptoms: a double-blinded, randomised controlled trial.坦索罗辛和安慰剂与坦索罗辛和他达拉非治疗男性下尿路症状的比较：一项双盲、随机对照试验。
BJU Int. 2020 May;125(5):718-724. doi: 10.1111/bju.15027. Epub 2020 Feb 27.
3
Tadalafil 5 mg Alone or in Combination with Tamsulosin 0.4 mg for the Management of Men with Lower Urinary Tract Symptoms and Erectile Dysfunction: Results of a Prospective Observational Trial.他达拉非5毫克单药治疗或与坦索罗辛0.4毫克联合治疗下尿路症状合并勃起功能障碍男性的疗效：一项前瞻性观察性试验的结果
J Clin Med. 2019 Jul 29;8(8):1126. doi: 10.3390/jcm8081126.
4
Sildenafil citrate in combination with tamsulosin versus tamsulosin monotherapy for management of male lower urinary tract symptoms due to benign prostatic hyperplasia: A randomised, double-blind, placebo-controlled trial.枸橼酸西地那非联合坦索罗辛与坦索罗辛单药治疗良性前列腺增生引起的男性下尿路症状的疗效比较：一项随机、双盲、安慰剂对照试验
Arab J Urol. 2016 Dec 29;15(1):53-59. doi: 10.1016/j.aju.2016.11.001. eCollection 2017 Mar.
5
6
A comparative randomized prospective study to evaluate efficacy and safety of combination of tamsulosin and tadalafil vs. tamsulosin or tadalafil alone in patients with lower urinary tract symptoms due to benign prostatic hyperplasia.一项比较随机前瞻性研究，旨在评估坦索罗辛和他达拉非联合与坦索罗辛或他达拉非单药治疗良性前列腺增生所致下尿路症状的疗效和安全性。
J Sex Med. 2014 Jan;11(1):187-96. doi: 10.1111/jsm.12357. Epub 2013 Oct 25.
7
Comparative efficacy assessment of tamsulosin vs. tamsulosin plus tadalafil in the treatment of LUTS/BPH. Pilot study.坦索罗辛与坦索罗辛联合他达拉非治疗下尿路症状/良性前列腺增生的疗效比较评估。初步研究。
J Sex Med. 2008 Sep;5(9):2170-8. doi: 10.1111/j.1743-6109.2008.00940.x. Epub 2008 Jul 14.
Zotero 插件